Health Economics

1992 - 2025

Current editor(s): Alan Maynard, John Hutton and Andrew Jones

From John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 9, issue 8, 2000

Health economists meet the fourth tempter: drug dependency and scientific discourse pp. 659-667

Steve Morgan, Morris Barer and Robert Evans

Is there a trade‐off between longevity and quality of life in Grossman's pure investment model? pp. 669-680

Christoph Eisenring

Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature pp. 681-698

Damian Walker and Julia A. Fox‐Rushby

Cross‐subsidization in the market for employment‐related health insurance pp. 699-714

Alan C. Monheit and Thomas Selden

Estimating the cost of primary care training in ambulatory settings pp. 715-726

Andrew J. Hogan, Luisa Franzini and James R. Boex

Complete preferences over health states: a reply to the paper by Shiell et al pp. 727-728

Adam Oliver

Will our understanding of completeness ever be complete? pp. 729-731

Alan Shiell, Penelope Hawe and Janelle Seymour

Age and proximity to death as predictors of GP care costs: results from a study of nursing home patients pp. 733-738

Ciaran O'Neill, Lindsay Groom, Anthony J. Avery, Daphne Boot and Karine Thornhill

In pursuit of an improving National Health Service edited by Alain C. Enthoven. The Nuffield Trust, London, 1999. No. of pages: 126. ISBN 1‐902089‐37‐5 pp. 739-740

Ted Marmor

Cost‐value analysis in health care: making sense out of QALYs by Eric Nord. Cambridge University Press, Cambridge, 1999. No. of pages: 157. ISBN 0 521 64434 8 pp. 740-741

Alan Williams

The politics of Medicare (2nd Edition) by Theodore R Marmor. Aldine de Gruyter, New York, 2000. No. of pages xii+228. ISBN 0 202 30425 6 pp. 741-742

Martin Mckee

Volume 9, issue 7, 2000

Towards multidisciplinary research into health inequalities pp. 565-566

Adam Oliver and Richard Cookson

Working together for equity pp. 567-568

Douglas Black

Health inequalities: bringing the hidden assumptions into the open pp. 569-570

Rudolf Klein

Equity in the allocation of health care resources pp. 571-574

Trevor A. Sheldon and Peter C. Smith

Rationing for health equity: is it necessary? pp. 575-579

George Davey Smith, Stephen Frankel and Shah Ebrahim

The need for an interdisciplinary perspective on the social determinants of health pp. 581-583

Richard G. Wilkinson

Equity in health: a challenge for researchers and policy makers pp. 585-586

Alan Williams

Interpreting the rational addiction model pp. 587-598

Brian Ferguson

A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplasty pp. 599-609

Maiwenn J. Al and Ben A. Van Hout

The social value of health programmes: is age a relevant factor? pp. 611-621

Eva Rodríguez and Jose-Luis Pinto-Prades

Definition, interpretation and calculation of cost‐effectiveness acceptability curves pp. 623-630

Mickael Löthgren and Niklas Zethraeus

Institutional considerations in priority setting: transactions cost perspective on PBMA pp. 631-641

Stephen Jan

The price of placements in residential and nursing home care: the effects of contracts and competition pp. 643-657

Julien Forder and Ann Netten

Volume 9, issue 6, 2000

Guest editors' introduction pp. 463-464

Andrew Jones and Owen O'Donnell

Identifying demand for health resources using waiting times information pp. 465-474

Richard Blundell and Frank Windmeijer

Estimates of use and costs of behavioural health care: a comparison of standard and finite mixture models pp. 475-489

Partha Deb and Ann M. Holmes

The effect of smoking on health using a sequential self‐selection model pp. 491-511

Kajal Lahiri and Jae Song

The use of long‐term care services by the Dutch elderly pp. 513-531

France Portrait, Maarten Lindeboom and Dorly Deeg

Health services utilization of elderly Swiss: evidence from panel data pp. 533-545

Martin Schellhorn, Andreas E. Stuck, Christoph E. Minder and John C. Beck

Regional differences in health care delivery: implications for a national resource allocation formula pp. 547-559

Matthew Sutton and Peter Lock

A note on risk adjustment and fair compensation pp. 561-564

Amir Shmueli

Volume 9, issue 5, 2000

Burden of disease and priority setting pp. 369-372

Gavin Mooney and Virginia Wiseman

Using health production functions to evaluate treatment effectiveness: an application to a community mental health service pp. 373-383

Andrew Healey, Massimo Mirandola, Francesco Amaddeo, Paola Bonizzato and Michele Tansella

Preference measurement using conjoint methods: an empirical investigation of reliability pp. 385-395

Stirling Bryan, Lisa Gold, Rob Sheldon and Martin Buxton

Cost function estimation: the choice of a model to apply to dementia pp. 397-409

Christian Kronborg, Kjeld Andersen and Per Kragh‐Sørensen

The cost‐effectiveness of evidence‐based guidelines and practice for screening and prevention of tuberculosis pp. 411-421

C.R. Macintyre, A.J. Plant and D. Hendrie

Determinants of ambulatory treatment mode for mental illness pp. 423-434

Marc P. Freiman and Samuel H. Zuvekas

A multilevel modelling approach to analysis of patient costs under managed care pp. 435-446

Kathleen Carey

Competition and dental services pp. 447-461

Jostein Grytten and Rune Sørensen

Volume 9, issue 4, 2000

Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay pp. 277-294

Boyd H. Gilman

Willingness to pay for improved respiratory and cardiovascular health: a multiple‐format, stated‐preference approach pp. 295-317

F. Reed Johnson, Melissa Ruby Banzhaf and William H. Desvousges

Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan pp. 319-326

Jin‐Tan Liu, James Hammitt, Jung‐ Der Wang and Jin‐Long Liu

Fieller's method and net health benefits pp. 327-335

Daniel F. Heitjan

Evidence‐based medicine and health economics: a case study of end stage renal disease pp. 337-351

Luke Vale, Cam Donaldson, Conal Daly, Marion Campbell, June Cody, Adrian Grant, Izhar Khan, Paul Lawrence, Shiela Wallace and Alison Macleod

Discrete time representation of the formula for calculating DALYs pp. 353-365

Elamin H. Elbasha

Volume 9, issue 3, 2000

Health economics: an evolving paradigm pp. 183-190

Alan Maynard and Panos Kanavos

Centre‐specific or average unit costs in multi‐centre studies? Some theory and simulation pp. 191-198

Maria Raikou, A. Briggs, Alastair Gray and A. McGuire

The effect of capitation on GPs' referral decisions pp. 199-210

Tor Iversen and Hilde Lurås

Can cost shifting continue in a price competitive environment? pp. 211-226

Jack Zwanziger, Glenn A. Melnick and Anil Bamezai

Power and sample assessments for tests of hypotheses on cost‐effectiveness ratios pp. 227-234

Joseph C. Gardiner, Marianne Huebner, James Jetton and Cathy J. Bradley

Development of WHO guidelines on generalized cost‐effectiveness analysis pp. 235-251

Christopher J.L. Murray, David B. Evans, Arnab Acharya and Rob M.P.M. Baltussen

Uncertainty aversion: a reply to the paper by Andersson and Lyttkens pp. 253-255

Adam Oliver

Uncertainty aversion—a reply to Oliver pp. 257-259

Fredrik Andersson and Carl Hampus Lyttkens

Uncertainty aversion: a discussion of critical issues in health economics pp. 261-263

Peter Wakker

The veil of experience: do consumers prefer what they know best? pp. 267-270

G. Salkeld, M. Ryan and L. Short

Volume 9, issue 2, 2000

A nice challenge for health economics pp. 89-93

John Hutton and Alan Maynard

Enhancing performance in health care: a theoretical perspective on agency and the role of information pp. 95-107

Maria Goddard, Russell Mannion and Peter Smith

Sensitivity and perspective in the valuation of health status: whose values count? pp. 109-126

G. Ardine De Wit, Jan J.V. Busschbach and Frank Th. De Charro

Societal value, the person trade‐off, and the dilemma of whose values to measure for cost‐effectiveness analysis pp. 127-136

Peter A. Ubel, Jeff Richardson and Paul Menzel

Public preferences for the allocation of donor liver grafts for transplantation pp. 137-148

Julie Ratcliffe

Establishing health state valuations for disease specific states: an example from heart disease pp. 149-158

J. Kirsch and A. McGuire

The impact of clean indoor‐air laws and cigarette smuggling on demand for cigarettes: an empirical model pp. 159-170

Ayda A. Yurekli and Ping Zhang

Negative and zero time preference for health pp. 171-175

Marjon van der Pol and John A. Cairns

Are QALYs an appropriate measure for valuing morbidity in acute diseases? pp. 177-180

Mohan V. Bala and Gary A. Zarkin

Volume 9, issue 1, 2000

Managed care in the United States: a dilemma for evidence‐based policy? pp. 1-7

Ray Robinson

The relationship between marijuana initiation and dropping out of high school pp. 9-18

Jeremy Bray, Gary A. Zarkin, Chris Ringwalt and Junfeng Qi

Policy analysis of the use of hepatitis B, Haemophilus influenzae type b‐, Streptococcus pneumoniae‐conjugate and rotavirus vaccines in national immunization schedules pp. 19-35

Mark A. Miller and Laura McCann

Measuring productivity loss days in asthma patients pp. 37-46

Wendy J. Ungar, Peter C. Coyte and The Pharmacy Medication Monitoring Program Advisory Board

Are preferences over health states complete? pp. 47-55

Alan Shiell, Janelle Seymour, Penelope Hawe and Sue Cameron

QALYs and ageism: philosophical theories and age weighting pp. 57-68

Aki Tsuchiya

Progress and directions in refining the Global Burden of Disease approach: a response to Williams pp. 69-82

Christopher J.L. Murray and Alan D. Lopez

Comments on the response by Murray and Lopez pp. 83-86

Alan Williams